TP53 and breast cancer: Among these molecules, epidermal growth factor receptor/ERBB2 [27], Wnt/β-catenin [28], p53 [29], UDP-glucuronosyltransferase-1A [30], CD24 [31], GATA3 [32], and Slug [33] are shown to be activated or inhibited by AR signals in BC or non-neoplastic urothelial cells.